The chemotherapy of rodent malaria. LX. The importance of formulation in evaluating the blood schizontocidal activity of some endoperoxide antimalarials

Annals of Tropical Medicine and Parasitology

Volumn 96, Issue 6, 2002, Pages 559-573

  Peters, W ^a   Fleck, S L ^a   Robinson, B L ^a   Stewart, L B ^a   Jefford, C W ^a  

^a NORTHWICK PARK INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,4 TRIOXANE DERIVATIVE; ANTIMALARIAL AGENT; ARTEETHER; ARTEFLENE; ARTEMETHER; ARTEMISININ; ARTESUNATE; BETA CYCLODEXTRIN; CARBOXYMETHYLCELLULOSE; CHLOROQUINE; CORN OIL; COTTON SEED OIL; DIHYDROARTEMISININ; DIMETHYL SULFOXIDE; ENDOPEROXIDE; FENOZAN B07; MACROGOL; POLYSORBATE 80; SESAME SEED OIL; SUSPENDING AGENT; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; AQUEOUS SOLUTION; ARTICLE; BLOOD; CHEMOTHERAPY; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG FORMULATION; DRUG POTENCY; DRUG SENSITIVITY; DRUG SOLUBILITY; FIRST PASS EFFECT; MALARIA; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PLASMODIUM YOELII; RODENT; SCHIZONT; STRUCTURE ACTIVITY RELATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIMALARIALS; ARTEMISININS; BICYCLO COMPOUNDS, HETEROCYCLIC; CHEMISTRY, PHARMACEUTICAL; CORN OIL; DRUG CARRIERS; DRUG EVALUATION, PRECLINICAL; INJECTIONS, SUBCUTANEOUS; LIPIDS; MALARIA; MICE; PARASITEMIA; PEROXIDES; PLASMODIUM BERGHEI; PLASMODIUM YOELII; SESQUITERPENES; SPIRO COMPOUNDS; STYRENES; WATER;

ANIMALIA; GOSSYPIUM HIRSUTUM; PLASMODIUM BERGHEI; PLASMODIUM YOELII; PROTOZOA; RODENTIA; SESAMUM INDICUM; SIMIAE; SUGARCANE STREAK VIRUS;

EID: 0036742376     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/000349802125001744     Document Type: Article

References (18)

1. Avery, M. A., McLean, G., Edwards, G. & Ager, A. (1999). Structure-activity relationships of peroxide-based artemisinin antimalarials. In Biologically Active Natural Products: Pharmaceuticals, eds Cutler, H. & Cutler, S. pp. 121-132. Boca Raton, FL: CRC Press.
2. Binh, T. Q., Ilett, K. F., Batty, K. T., Davis, T. M. E., Hung, N. G., Powell, S. M., Thu, L. T. A., Van Thien, H., Phuo-Ng, H. L. & Phuong, V. D. B. (2001). Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malaria. British Journal of Clinical Pharmacology, 51, 541-546.
3. Fleck, S. L., Robinson, B. L., Peters, W., Thévin, F., Boulard, Y., Glénat, C., Vaillard, V. & Landau, I. (1997). The chemotherapy of rodent malaria. LIII. 'Fenozan B07 (Fenozan-50F)', a difluorinated 3,3′-spirocyclopentane 1,2,4-trioxane: comparison with some compounds of the artemisinin series. Annals of Tropical Medicine and Parasitology, 91, 25-32.
4. Girometta, M. A., Jauch, R., Ponelle, C. H., Guenzi, A. & Wiegand-Chou, R. C. (1994). Animal pharmacokinetics and metabolism of the new anti-malarial Ro42-1611 (arteflene). Tropical Medicine and Parasitology, 45, 272-277.
5. Haynes, R. K. (2001). Artemisinin and derivatives: the future for malaria treatment? Current Opinion in Infectious Diseases, 14, 719-726.
6. Jaquet, C., Stohler, H. R., Chollet, J. & Peters, W. (1994). Antimalarial activity of the bicyclic peroxide Ro42-1611 (arteflene) in experimental models. Tropical Medicine and Parasitology, 45, 266-271.
7. Jefford, C. W. (1997). Peroxidic antimalarials. Advances in Drug Research, 29, 271-325.
8. Jefford, C. W. (2001). Why artemisinin and certain synthetic peroxides are potent antimalarials. Implications for the mode of action. Current Medicinal Chemistry, 8, 1803-1826.
9. Jefford, C. W., Kohmoto, S., Jaggi, D., Timari, G., Rossier, J.-C., Rudaz, M., Barbuzzi, O., Gerard, D., Burger, U., Kamalaprija, P., Mareda, J., Bernardinelli, G., Manzanares, I., Canfield, C. J., Fleck, S. L., Robinson, B. L. & Peters, W. (1995). Synthesis, structure, and antimalarial activity of some enantiomerically pure, cis-fused cyclopenteno-1,2,4-trioxanes. Helvetica Chimica Acta, 78, 647-662.
10. Meshnick, S. R., Jefford, C. W., Posner, G. H., Avery, M. A. & Peters, W. (1996). Second-generation antimalarial endoperoxides. Parasitology Today, 12, 79-82.
11. Peters, W. & Robinson, B. L. (1998). Malaria. In Handbook of Animal Models for Infection, eds Zak, O. & Sande, M. pp. 756-771. London: Academic Press.
12. Peters, W. & Robinson, B. L. (1999) The chemotherapy of rodent malaria. LVI. Studies on the development of resistance to natural and synthetic endoperoxides. Annals of Tropical Medicine and Parasitology, 93, 325-339.
13. Peters, W., Portus, J. H. & Robinson, B. L. (1975). The chemotherapy of rodent malaria. XXII. The value of drug-resistant strains of P. berghei in screening for blood schizontocidal activity. Annals of Tropical Medicine and Parasitology, 69, 155-171.
14. Peters, W., Robinson, B. L., Tovey, G., Rossier, J. C. & Jefford, C. W. (1993). The chemotherapy of rodent malaria. L. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine-resistant parasites. Part 3. Observations on 'Fenozan-50F', a difluorinated 3,3′-spirocyclopentane 1,2,4-trioxane. Annals of Tropical Medicine and Parasitology, 87, 111-123.
15. Posner, G. H., Cumming, J. N. & Krasavin, M. (2000). Carbon-centered radicals and rational design of new antimalarial peroxide drugs. In Biomedical Chemistry. Applying Chemical Principles to the Understanding and Treatment of Disease, ed. Torrence, P. F. pp. 289-309. New York: A. J. Wiley.
16. Radloff, P. D., Philipps, J., Nkeyi, M., Sturchler, D., Mittelholzer, M. L. & Kremsner, P. G. (1996). Arteflene compared with mefloquine for treating Plasmodium falciparum malaria in children. American Journal of Tropical Medicine and Hygiene, 55, 259-262.
17. Salako, L. A., Guiguemde, R., Mittelholzer, M.-L., Haller, L., Sorenson, F. & Stürchler, D. (1996). Ro 42-1611 in the treatment of patients with mild malaria: a clinical trial in Nigeria and Burkina Faso. Tropical Medicine and Parasitology, 45, 284-287.
18. Vroman, J. A., Alvim-Gaston, M. & Avery, M. A. (1999). Current progress in the chemistry, medicinal chemistry and drug design of artemisinin based anti-malarials. Current Pharmaceutical Design, 5, 101-138.